Arena Pharmaceuticals Inc. (ARNA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arena Pharmaceuticals Inc...

    NASDAQ: ARNA · Real-Time Price · USD
    99.99
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Arena Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Cash & Equivalents
    		 224.57M
    Short-Term Investments
    		 325.9M
    Long-Term Investments
    		 160.8M
    Other Long-Term Assets
    		 35.32M
    Receivables
    		 n/a
    Inventory
    		 n/a
    Other Current Assets
    		 19M
    Total Current Assets
    		 569.47M
    Property-Plant & Equipment
    		 19.13M
    Goodwill & Intangibles
    		 n/a
    Total Long-Term Assets
    		 215.24M
    Total Assets
    		 784.71M
    Account Payables
    		 13.3M
    Deferred Revenue
    		 n/a
    Short-Term Debt
    		 5.05M
    Other Current Liabilities
    		 47.96M
    Total Current Liabilities
    		 66.32M
    Long-Term Debt
    		 36.16M
    Other Long-Term Liabilities
    		 8.99M
    Total Long-Term Liabilities
    		 45.15M
    Total Liabilities
    		 111.47M
    Total Debt
    		 41.21M
    Book Value
    		 673.24M
    Book Value Per Share
    		 12.29
    Common Stock
    		 6K
    Retained Earnings
    		 -2.12B
    Comprehensive Income
    		 -280K
    Shareholders Equity
    		 673.24M
    Total Investments
    		 486.69M

    Add to Watchlist